Olinciguat, an Oral sGC Stimulator, Exhibits Diverse Pharmacology Across Preclinical Models of Cardiovascular, Metabolic, Renal, and Inflammatory Disease-Reference-Cited by-同舟云学术

Olinciguat, an Oral sGC Stimulator, Exhibits Diverse Pharmacology Across Preclinical Models of Cardiovascular, Metabolic, Renal, and Inflammatory Disease

Published:2020-04-08 Issue: Volume:11 Page:
ISSN:1663-9812
Container-title:Frontiers in Pharmacology
language:
Short-container-title:Front. Pharmacol.

Author:

Zimmer Daniel P.,Shea Courtney M.,Tobin Jenny V.,Tchernychev Boris,Germano Peter,Sykes Kristie,Banijamali Ali R.,Jacobson Sarah,Bernier Sylvie G.,Sarno Renee,Carvalho Andrew,Chien Yueh-tyng,Graul Regina,Buys Emmanuel S.,Jones Juli E.,Wakefield James D.,Price Gavrielle M.,Chickering Jennifer G.,Milne G. Todd,Currie Mark G.,Masferrer Jaime L.

Publisher

Frontiers Media SA

Subject

Pharmacology (medical),Pharmacology

Reference39 articles.

1. Antiinflammatory activity of soluble guanylate cyclase: cGMP-dependent down-regulation of P-selectin expression and leukocyte recruitment;Ahluwalia;Proc. Natl. Acad. Sci. U. S. A.,2004

2. Nitrates as a Treatment of Acute Heart Failure;Alzahri;Card. Fail. Rev.,2016

3. Diabetic nephropathy and long-term treatment effects of rosiglitazone and enalapril in obese ZSF1 rats;Bilan;J. Endocrinol.,2011

4. Characterization of liver changes in ZSF1 rats, an animal model of metabolic syndrome;Borges Canha;Rev. Esp. Enferm. Dig.,2017

5. Tissue distribution of the human soluble guanylate cyclases;Budworth;Biochem. Biophys. Res. Commun.,1999

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Decoding signaling mechanisms: unraveling the targets of guanylate cyclase agonists in cardiovascular and digestive diseases;Frontiers in Pharmacology;2023-12-20

2. Regulation of renal nitric oxide and eNOS/iNOS expression by tadalafil participates in the mitigation of amphotericin B–induced renal injury: Down-regulation of NF-κB/iNOS/caspase-3 signaling;Naunyn-Schmiedeberg's Archives of Pharmacology;2023-10-28

3. Many drugs are available for hypertension, with more in development;Drugs & Therapy Perspectives;2022-11-15

4. Activating NO–sGC crosstalk in the mouse vascular niche promotes vascular integrity and mitigates acute lung injury;Journal of Experimental Medicine;2022-11-09

5. Role of protein phosphorylation in cell signaling, disease, and the intervention therapy;MedComm;2022-11-03